The ‘East Asian Paradox’ refers to a unique risk-benefit trade-off observed in Asian patients for thrombosis versus bleeding, ...
Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales
Background Infants with congenital heart disease (CHD) are clinically vulnerable to cardiac deteriorations and intercurrent ...
While iterative developments have improved outcomes of patients with myocardial infarction, mortality in patients with acute ...
Background Over the past three decades, significant disparities in the global burden of cardiovascular disease (CVD) have ...
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...
Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...
Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the risk factors associated with ...
Background Primary prevention strategies for cardiovascular disease (CVD) conventionally rely on 10-year risk estimates of major adverse cardiovascular events (MACE). However, communicating ...
Background and objective This review compares non-laboratory-based and laboratory-based cardiovascular disease (CVD) risk prediction equations in populations targeted for primary prevention. Design ...
Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ongoing controversy regarding optimal anti-thrombotic therapy post-MVr. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback